The members of the Management and Therapy Subcommittee undertook an evidence-
based review of current dry eye therapies and management options. Management options …

Preservatives in multidose formulations of topical ophthalmic medications are crucial for
maintaining sterility but can be toxic to the ocular surface. Benzalkonium chloride (BAK) …

Dry eye can be caused by a variety of iatrogenic interventions. The increasing number of
patients looking for eye care or cosmetic procedures involving the eyes, together with a …

Dry eye disease (DED), keratoconjunctivitis sicca or dysfunctional tear syndrome, is the most
prevalent ophthalmic disease which affects a substantial segment of people worldwide with …

Conjunctivitis is a commonly encountered condition in ophthalmology clinics throughout the
world. In the management of suspected cases of conjunctivitis, alarming signs for more …

There is a large body of evidence from experimental and clinical studies showing that the
long-term use of topical drugs may induce ocular surface changes, causing ocular …

The ultimate goal of glaucoma management is the preservation of patients' visual function
and quality of life (QoL). The disease itself as well as the medical or surgical treatment can …

Dry eye disease (DED) is a growing public health concern causing ocular discomfort,
fatigue, and visual disturbance that interferes with quality of life (QoL), including aspects of …

Dry Eye Syndrome Preferred Practice Pattern® - Ophthalmology Skip to Main Content
Advertisement Ophthalmology Home Page AAO Submit Log in Register Log in Submit Log …

Dry eye disease (DED) is one of the most common ocular surface disorders characterised by
a deficiency in quality and/or quantity of the tear fluid. Due to its multifactorial nature …